Orexigen Therapeutics, Inc. Recalls

FDA
2
Total Recalls
1
Agencies
Aug 2018
First Recall
Nov 2018
Latest Recall
Sort: Newest first Highest severity

Showing 1-2 of 2 recalls

FDA

Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99

Container packaging defect.
FDA

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Defective Container: Customer complaints of punctures in the bottle.